Partial treatment response to alectinib in metastatic non-small cell lung cancer with KIDINS220-ALK fusion.

Precis Clin Med · 2023 · PMC10251428 · PMID 37305526

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

DNA-based NGS, fluorescence in situ hybridization, RNA and IHC assays may be significant in detecting the ALK rearrangements.

also in 4,626 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.